Press release
Know Worldwide specifications of the Cetirizine Hydrochloride Market Size 2023-2033 | Top Key Players: Sun Pharmaceutical Industries, Teva Pharmaceuticals, Glenmark Pharmaceuticals, Alembic Pharmaceuticals, Sanofi, Pfizer Inc., and others.
According to a research report published by Spherical Insights & Consulting, the Global Cetirizine Hydrochloride Market Size is Expected to Grow from USD 6.14 Billion in 2023 to USD 7.88 Billion by 2033 at a CAGR of 2.53% during the forecast period 2023-2033.Request To Download Free Sample copy of the report: https://www.sphericalinsights.com/request-sample/8282
The global cetirizine hydrochloride market aims to develop, produce, and distribute stable dosages of cetirizine hydrochloride for managing allergic diseases. It is a selective second-generation antihistamine and is available in tablets, capsules, and liquid forms, with a daily dose of 10mg for adults and lower doses for kidney-related individuals. Government strategies, such as banning fixed-dose combinations (FDC) medicines, have contributed to the growth of the market. The versatility and safety profile of cetirizine hydrochloride have increased its market potential, making it a reliable option for patients of any age group. The introduction of generic versions has also strengthened its commercial appeal, making it more accessible to a wider range of individuals. Increased awareness and self-medication adoption have further accelerated the cetirizine hydrochloride market growth. As the prevalence of allergies worldwide rises, grows the need for cetirizine hydrochloride. Market expansion is fueled by researchers' attention to stability, effectiveness, and tailored delivery. Transdermal patches for children and elderly patients are being developed by researchers and have FDA approval for treating allergic rhinitis and chronic urticaria. However, side effects derived from the cetirizine hydrochloride may impede the market growth.
The tablets segment held the largest share in 2023 and is expected to grow at a significant CAGR throughout the predicted timeframe.
Based on the dosage form, the global cetirizine hydrochloride market is categorized as tablets, solutions, and capsules. Among these, the tablets segment held the largest share in 2023 and is expected to grow at a significant CAGR throughout the predicted timeframe. The segmental expansion of cetirizine hydrochloride tablets is driven by its ease of use, accuracy in dosing, availability in various dosages, preference among healthcare professionals, stability, and cost-effectiveness.
The allergic rhinitis segment dominated the global cetirizine hydrochloride market in 2023 and is anticipated to grow at a substantial CAGR throughout the projected timeframe.
Based on the applications, the global cetirizine hydrochloride market is categorized into allergic conjunctivitis, allergic rhinitis, eczema, chronic urticaria, and others. Among these, the allergic rhinitis segment dominated the global cetirizine hydrochloride market in 2023 and is anticipated to grow at a substantial CAGR throughout the projected timeframe. The segment's growth is ascribed to the increasing prevalence of allergic rhinitis, a major public health concern affecting 400 million people, pollen aggregation, allergen exposure, air pollution, and global warming.
The hospital pharmacies segment accounted for the greatest share in 2023 and is anticipated to grow at a remarkable CAGR during the projected timeframe.
Based on the end-user, the global cetirizine hydrochloride market is categorized as retail pharmacies, online pharmacies, and hospital pharmacies. Among these, the hospital pharmacies segment accounted for the greatest share in 2023 and is anticipated to grow at a remarkable CAGR during the projected timeframe. The growth of the segment is driven by patient adoption, accessibility of nanoformulations of cetirizine, improved facilities, medication monitoring services, hospital admissions, and cost-effective medication discounts.
Buy Now this report: https://www.sphericalinsights.com/checkout/8282
North America is expected to hold the greatest share of the global cetirizine hydrochloride market over the forecast period.
North America is expected to hold the greatest share of the global cetirizine hydrochloride market over the forecast period. North America is expected to lead the growth of the cetirizine hydrochloride market due to its high prevalence of allergic illnesses, sophisticated healthcare system, and increased awareness of allergy-related concerns. Government initiatives and rising seasonal allergies further enhance market potential.
Asia Pacific is predicted to hold the fastest-growing region of the global cetirizine hydrochloride market throughout the estimated period. Companies are localizing their products and expanding their distribution networks as a result of the growing demand for cetirizine hydrochloride and related treatments throughout Asia-Pacific, especially China and India, due to urbanization and rising healthcare expenditures.
Major key players in the global cetirizine hydrochloride market are Aurobindo Pharma Limited, Cipla Limited, Jubilant Pharma Sciences, Lupin Pharmaceuticals, Hetero Drugs, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Glenmark Pharmaceuticals, Alembic Pharmaceuticals, Sanofi, Pfizer Inc., and others.
Key Target Audience
Market Players
Investors
End-users
Government Authorities
Consulting and Research Firm
Venture capitalists
Value-Added Resellers (VARs)
Access Full Report: https://www.sphericalinsights.com/reports/cetirizine-hydrochloride-market
Recent Development
In October 2024, Indoco Remedies received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets USP, 10mg (OTC). The product is a generic equivalent of the Reference Listed Drug, Zyrtec Allergy Tablets, 10 mg, manufactured by Johnson & Johnson Consumer Inc.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global cetirizine hydrochloride market based on the below-mentioned segments:
Global Cetirizine Hydrochloride Market, By Dosage Form
Tablets
Solutions
Capsules
Global Cetirizine Hydrochloride Market, By Application
Allergic Conjunctivitis
Allergic Rhinitis
Eczema
Chronic Urticaria
Others
Global Cetirizine Hydrochloride Market, By End-User
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Global Cetirizine Hydrochloride Market, By Regional
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of the Middle East & Africa
Related URLS
https://www.sphericalinsights.com/reports/allogeneic-stem-cell-transplantation-market
https://www.sphericalinsights.com/reports/iron-ore-mining-market
https://www.sphericalinsights.com/reports/3d-imaging-distance-service-market
https://www.sphericalinsights.com/reports/underbalanced-drilling-market
https://www.sphericalinsights.com/reports/ai-glasses-market
https://www.sphericalinsights.com/reports/smart-hospitality-management-market
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Know Worldwide specifications of the Cetirizine Hydrochloride Market Size 2023-2033 | Top Key Players: Sun Pharmaceutical Industries, Teva Pharmaceuticals, Glenmark Pharmaceuticals, Alembic Pharmaceuticals, Sanofi, Pfizer Inc., and others. here
News-ID: 4183157 • Views: …
More Releases from Spherical Insights LLP

Global Retail Automation Market Size, Share, Forecasts 2023 - 2033 | Top key pla …
According to a research report published by Spherical Insights & Consulting, the Global Retail Automation Market Size Expected to Grow from USD 24.09 Billion in 2023 to USD 59.17 Billion by 2033, at a CAGR of 9.4% during the forecast period 2023-2033.
Request To Download Free Sample copy of the report: https://www.sphericalinsights.com/request-sample/8265
The global retail automation market refers to the integration of technology and automated systems in retail operations to…

Global Connected Retail Market Size, Share, Forecasts 2023 - 2033 | Top key play …
According to a research report published by Spherical Insights & Consulting, The Global Connected Retail Market Size is Estimated to Grow from USD 30.81 Billion in 2023 to USD 97.25 Billion by 2033, Growing at a CAGR of 12.18% during the forecast period 2023-2033.
Request To Download Free Sample copy of the report: https://www.sphericalinsights.com/request-sample/8263
The use of technology to integrate many aspects of the retail industry, such as supply chain management,…

Know Worldwide specifications of the Recycled Cotton Market Size 2023-2033 | Top …
According to a research report published by Spherical Insights & Consulting, The Global Recycled Cotton Market Size is Expected to Grow from 5.02 Billion in 2023 to USD 9.95 Billion by 2033, at a CAGR of 7.08% during the forecast period 2023-2033.
Request To Download Free Sample copy of the report: https://www.sphericalinsights.com/request-sample/8276
The collection, classification, and processing of post-consumer or discarded cotton textiles to create new, useful fibers is the focus…

Global Synthetic Dyes Market Size, Share, Forecasts 2023 - 2033 | Top key player …
According to a research report published by Spherical Insights & Consulting, the Global Synthetic Dyes Market Size is Expected to Grow from USD 6.27 Billion in 2023 to USD 12.04 Billion by 2033, at a CAGR of 6.74% during the forecast period 2023-2033.
Request To Download Free Sample copy of the report: https://www.sphericalinsights.com/request-sample/8277
The synthetic dyes market is the industry that manufactures, distributes, and sells man made dyes. Synthetic…
More Releases for Cetirizine
Cetirizine Hydrochloride Market Anticipated for Positive Expansion by 2031
Cetirizine Hydrochloride Market analysis, according to DataM Intelligence, offers more than just an overview; it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Cetirizine Hydrochloride market emerge as the sector's next great…
Cetirizine Hydrochloride Market Revenue, Insights, Overview, Outlook, Analysis
Cetirizine Hydrochloride - Market Size
The global market for Cetirizine Hydrochloride was estimated to be worth US$ 839.2 million in 2023 and is forecast to a readjusted size of US$ 945.6 million by 2030 with a CAGR of 1.7% during the forecast period 2024-2030.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-23A4072/Global_Cetirizine_Hydrochloride_Market_Research_Report_2021
The major players in the industry are J & J, UCB Pharma, GSK, etc. The proportion of revenue in 2019 is 29.00%, 25.87%, 11.39%. North…
Cetirizine (Zyrtec) Manufacturing Plant Project Report 2023: Raw Materials and I …
IMARC Group's report titled "Cetirizine (Zyrtec) Manufacturing Plant Project Report 2023: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a cetirizine (zyrtec) manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In…
Cetirizine Hydrochloride Market Set To Witness An Uptick During 2020-2030
This research study on "Cetirizine Hydrochloride market" reports offers the comparative assessment of Cetirizine Hydrochloride market and consist of Historical data, Significance, statistical data, size & share, Market Price & Demand, Business overview, Market Analysis By Product and Market Trends by Key Players. This Cetirizine Hydrochloride Market is Segmented in two type on the basis of type of materials and end-users. It has global market covered in all the regions,…
Pharma and Cetirizine OTC Market Size, Share, Development by 2024
Market Research Report Store offers a latest published report on Pharma and Cetirizine OTC Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Pharma and Cetirizine OTC market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx…
Cetirizine Hydrochloride Market 2017- UCB Pharma, Pfizer, J & J, Mylan
Cetirizine Hydrochloride Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors.
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
Second-generation antihistamines like cetirizine…